MiraBiologics Inc.

We bring the “Miracle in medicine” for a better Future/Mirai to the lives of people.

Latest NewsMore News

August 10, 2021InformationNEW
Aug 10: Our Company entered into a drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. (TSE First Section: Securities Code 4528) to create next-generation biopharmaceuticals using our proprietary LassoGraft Technology that integrates cyclic peptide discovery method (RaPID System) with protein engineering (PDF attached).
March 10, 2021InformationNEW
Mar 9: A paper on Lassograft Technology by Prof. Junichi Takagi, Osaka University, and Prof. Hiroaki Suga, University of Tokyo, was published in the Nature Communications (Nature Commun 12, 1543 (2021). https://doi.org/10.1038/s41467-021-21875-0).
November 26, 2020Information
Nov 20:  A paper on Lassograft Technology by Prof. Junichi Takagi, Osaka University, and Prof. Hiroaki Suga, University of Tokyo, was published in the Preprint (a Nature Research journal).
June 29, 2020Information
Jun 29:  Our company has been selected for NEDO’s (New Energy and Industrial Technology Development Organization) FY2020 “Research and Development Venture Support Program / Commercialization Support for Research and Development Ventures at Seed Stage”. The title of the grant is “Verification of the Pharmaceutical Properties of Met Agonists for the Treatment of NASH” and we will promote our own development project.
January 27, 2020Information
Feb 8 [Japanese Only] President Kato appeared at BS Fuji “konokuninoyukusue2 (every Saturday from 18:00 to 18:30)”, introduced our business (Part 2).
There are no articles yet.

Access

Building layout around Komaba Open Laboratory

Nearest station

    • 20 minutes' walk from Yoyogi-Uehara, Odakyu Line
    • 8 minutes' walk from Higashi-Kitazawa, Odakyu Line
    • 12 minutes' walk from Komaba-Todaimae, Inokashira Line
    • 8 minutes' walk from Ikenoue, Inokashira Line

 

Location

MiraBiologics Inc.

Komaba Open Laboratory 5th Floor, 4-6-1 Komaba,
Meguro-ku, Tokyo, Japan, 153-0041
Contact : mail
Print this page, click here